CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
14,662
edits
Arthritis Advisory Committee: Difference between revisions
no edit summary
m (Text replacement - "{{<span class="error">Expansion depth limit exceeded</span>" to "{{Organization") Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 1: | Line 1: | ||
{{Organization | |||
{{Organization|OrganizationName=Arthritis Advisory Committee | |OrganizationName=Arthritis Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission=The Arthritis Advisory Committee provides expert advice to the FDA on issues related to arthritis, rheumatism, and related diseases. Its mission is to ensure the safety, efficacy, and appropriate use of drug products for these conditions by reviewing scientific data and offering recommendations. | |Mission=The Arthritis Advisory Committee provides expert advice to the FDA on issues related to arthritis, rheumatism, and related diseases. Its mission is to ensure the safety, efficacy, and appropriate use of drug products for these conditions by reviewing scientific data and offering recommendations. | ||
| Line 18: | Line 18: | ||
'''Arthritis Advisory Committee (AAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters concerning the treatment of arthritis, rheumatism, and related conditions. Located in Silver Spring, Maryland, the committee evaluates data on drug safety, effectiveness, and labeling related to these diseases. | '''Arthritis Advisory Committee (AAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters concerning the treatment of arthritis, rheumatism, and related conditions. Located in Silver Spring, Maryland, the committee evaluates data on drug safety, effectiveness, and labeling related to these diseases. | ||
{{ | {{Official URL (simple)|url=https://www.fda.gov/advisory-committees/arthritis-advisory-committee}} | ||
==Mission== | ==Mission== | ||
The mission of the AAC is to review and evaluate data concerning drug products for arthritis and rheumatism, providing recommendations to the FDA on approval, labeling, and post-marketing surveillance. It aims to facilitate the development of safe and effective treatments for these chronic conditions.< | The mission of the AAC is to review and evaluate data concerning drug products for arthritis and rheumatism, providing recommendations to the FDA on approval, labeling, and post-marketing surveillance. It aims to facilitate the development of safe and effective treatments for these chronic conditions.<ref>Food and Drug Administration (2025). [https://www.fda.gov/advisory-committees/arthritis-advisory-committee "Arthritis Advisory Committee"]. FDA.</ref> | ||
==Parent organization== | ==Parent organization== | ||
| Line 74: | Line 74: | ||
==Services provided== | ==Services provided== | ||
The AAC provides scientific and technical advice on drug products related to arthritis and related conditions. This includes reviewing clinical trials, safety data, and efficacy studies, and discussing the implications for public health.< | The AAC provides scientific and technical advice on drug products related to arthritis and related conditions. This includes reviewing clinical trials, safety data, and efficacy studies, and discussing the implications for public health.<ref>Food and Drug Administration (2025). [https://www.fda.gov/advisory-committees/committees-and-meeting-materials/human-drug-advisory-committees "Human Drug Advisory Committees"]. FDA.</ref> | ||
==Headquarters address== | ==Headquarters address== | ||
| Line 92: | Line 92: | ||
==References== | ==References== | ||
< | <references /> | ||